HeartSciences Inc. (HSCS) updates Fortitude Mining merger terms
Rhea-AI Filing Summary
HeartSciences Inc. entered into Amendment No. 1 to its June 23, 2026 Agreement and Plan of Merger with Fortitude Mining Holdings, Inc., Fortitude Mining HoldCo, LLC and Cordis Acquisition, LLC. The amendment replaces the form of the A&R LLC Agreement to clarify certain redemption mechanics.
The amendment also replaces the form of the Parent New Charter to provide for a proposed amendment to the requirements for HeartSciences shareholder action by written consent. HeartSciences plans to file a proxy statement with the SEC and mail it to stockholders in connection with the transactions contemplated by the amended merger agreement.
Positive
- None.
Negative
- None.
Insights
Analyzing...
8-K Event Classification
2 items: 1.01, 9.01
2 items
Item 1.01
Entry into a Material Definitive Agreement
Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Amendment date: July 27, 2026
Original merger agreement date: June 23, 2026
Amendment exhibit number: 2.2
3 metrics
Amendment date
July 27, 2026
Date HeartSciences entered into Amendment No. 1 to the merger agreement
Original merger agreement date
June 23, 2026
Date of the original Agreement and Plan of Merger with Fortitude entities
Amendment exhibit number
2.2
Exhibit number for Amendment No. 1 to Agreement and Plan of Merger
Key Terms
Agreement and Plan of Merger, A&R LLC Agreement, Parent New Charter, proxy statement, +1 more
5 terms
Agreement and Plan of Merger regulatory
"the previously announced Agreement and Plan of Merger, dated June 23, 2026"
An Agreement and Plan of Merger is a formal document where two companies agree to combine into one, outlining how the process will happen. It’s like a step-by-step plan for merging, and it matters because it shows both sides have agreed on the details before the official transition takes place.
A&R LLC Agreement regulatory
"replace the form of A&R LLC Agreement to clarify certain redemption mechanics"
Parent New Charter regulatory
"replace the form of Parent New Charter to provide for a proposed amendment"
proxy statement regulatory
"HeartSciences intends to file with the SEC a proxy statement"
A proxy statement is a document companies send to shareholders ahead of a meeting that lays out the items up for a vote—like who will sit on the board, executive pay, and major corporate decisions—and provides background so shareholders can decide how to cast their votes or appoint someone to vote for them. Think of it as an agenda plus a ballot and briefing notes, important because the outcomes can change control, strategy, and value.
Emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
How does the new amendment affect HeartSciences (HSCS) LLC redemption mechanics?
The amendment replaces the form of the Amended and Restated LLC Agreement to clarify certain redemption mechanics. This focuses on how redemptions will function in the post-transaction structure, without changing overall transaction amounts described elsewhere.
Will HeartSciences (HSCS) stockholders vote on the Fortitude transactions?
Yes. HeartSciences plans a proxy statement and a special meeting of stockholders to vote on the transactions and related matters, with definitive proxy materials to be mailed to stockholders of record as of a future specified date.
Where can HSCS investors find documents about the Fortitude merger transactions?
Investors will be able to access the proxy statement and other filings for free on the SEC’s website at www.sec.gov, once available, and are urged to review all such documents before making any voting or investment decision regarding the transactions.
Does the HeartSciences (HSCS) disclosure constitute an offer to sell securities?
No. The company states the information is for informational purposes only and does not constitute an offer to sell or solicit an offer to buy any securities or related instruments in any jurisdiction.